TrendingNews.today

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

As of Mar 30

GeneralUnited States1 sourcesNeutral

Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%

TM

tristan manalac

via Biospace

March 30, 2026 | 12:00 AM UTCUpdated 1h ago

Share Read original

Read the full article at Biospace →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments

Be respectful and constructive.

Loading comments...

Sophie Turner back injury shuts down filming on Lara Croft reboot

Managed wetlands a culinary hot spot for SF bay fish, but they need delivery options

Related Articles

Wakenya wahimizwa kufanyiwa ukaguzi mapema ili kujikinga na athari za saratani

Unknown-2h ago-1 sources

Mwenyekiti wa DAP Peter Ndubai ataka serikali kufidia waathiriwa wa wizi wa mifugo Meru

Unknown-2h ago-1 sources

IPOA yanakili visa 4,500 vya ukatili wa polisi Pwani huku kesi 19 pekee zikifikishwa mahakamani

Unknown-2h ago-1 sources

Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3% | TrendingNews.today